{
  "fullName": "William J. Sandborn",
  "slug": "william-j-sandborn",
  "title": "MD",
  "specialty": "Inflammatory Bowel Disease",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 198,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "\nThis is a list of members of the Portland City Council in Oregon, both past and present.",
  "aiSummary": "William J. Sandborn is a inflammatory bowel disease specialist with an H-index of 198 at University of California, San Diego (Faculty). Has been published in New England Journal of Medicine, The Lancet, Nature. Based in United States.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "University of California, San Diego",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Inflammatory Bowel Disease"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis",
      "journal": "New England Journal of Medicine",
      "year": 2005,
      "citationCount": 3836,
      "doi": "10.1056/nejmoa050516",
      "sourceUrl": "https://doi.org/10.1056/nejmoa050516",
      "verified": true
    },
    {
      "title": "Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease",
      "journal": "New England Journal of Medicine",
      "year": 2010,
      "citationCount": 3063,
      "doi": "10.1056/nejmoa0904492",
      "sourceUrl": "https://doi.org/10.1056/nejmoa0904492",
      "verified": true
    },
    {
      "title": "Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis",
      "journal": "New England Journal of Medicine",
      "year": 2013,
      "citationCount": 2771,
      "doi": "10.1056/nejmoa1215734",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1215734",
      "verified": true
    },
    {
      "title": "Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease",
      "journal": "New England Journal of Medicine",
      "year": 2013,
      "citationCount": 2635,
      "doi": "10.1056/nejmoa1215739",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1215739",
      "verified": true
    },
    {
      "title": "STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD",
      "journal": "Gastroenterology",
      "year": 2021,
      "citationCount": 2419,
      "doi": "10.1053/j.gastro.2020.12.031",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2020.12.031",
      "verified": true
    },
    {
      "title": "Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial",
      "journal": "Gastroenterology",
      "year": 2006,
      "citationCount": 2223,
      "doi": "10.1053/j.gastro.2006.11.041",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2006.11.041",
      "verified": true
    },
    {
      "title": "Crohn's disease",
      "journal": "The Lancet",
      "year": 2012,
      "citationCount": 2069,
      "doi": "10.1016/s0140-6736(12)60026-9",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(12)60026-9",
      "verified": true
    },
    {
      "title": "Ulcerative colitis",
      "journal": "The Lancet",
      "year": 2012,
      "citationCount": 1985,
      "doi": "10.1016/s0140-6736(12)60150-0",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(12)60150-0",
      "verified": true
    },
    {
      "title": "Inflammatory bowel disease: clinical aspects and established and evolving therapies",
      "journal": "The Lancet",
      "year": 2007,
      "citationCount": 1913,
      "doi": "10.1016/s0140-6736(07)60751-x",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(07)60751-x",
      "verified": true
    },
    {
      "title": "Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target",
      "journal": "The American Journal of Gastroenterology",
      "year": 2015,
      "citationCount": 1781,
      "doi": "10.1038/ajg.2015.233",
      "sourceUrl": "https://doi.org/10.1038/ajg.2015.233",
      "verified": true
    },
    {
      "title": "Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease",
      "journal": "New England Journal of Medicine",
      "year": 2016,
      "citationCount": 1737,
      "doi": "10.1056/nejmoa1602773",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1602773",
      "verified": true
    },
    {
      "title": "Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial",
      "journal": "Gastroenterology",
      "year": 2006,
      "citationCount": 1702,
      "doi": "10.1053/j.gastro.2005.11.030",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2005.11.030",
      "verified": true
    },
    {
      "title": "Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis",
      "journal": "New England Journal of Medicine",
      "year": 2017,
      "citationCount": 1656,
      "doi": "10.1056/nejmoa1606910",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1606910",
      "verified": true
    },
    {
      "title": "Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis",
      "journal": "Gastroenterology",
      "year": 2011,
      "citationCount": 1231,
      "doi": "10.1053/j.gastro.2011.10.032",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2011.10.032",
      "verified": true
    },
    {
      "title": "A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis",
      "journal": "Gastroenterology",
      "year": 2006,
      "citationCount": 1185,
      "doi": "10.1053/j.gastro.2006.12.038",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2006.12.038",
      "verified": true
    },
    {
      "title": "Management of Crohn's Disease in Adults",
      "journal": "The American Journal of Gastroenterology",
      "year": 2009,
      "citationCount": 1183,
      "doi": "10.1038/ajg.2008.168",
      "sourceUrl": "https://doi.org/10.1038/ajg.2008.168",
      "verified": true
    },
    {
      "title": "The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study",
      "journal": "Gastroenterology",
      "year": 2001,
      "citationCount": 1144,
      "doi": "10.1053/gast.2001.26279",
      "sourceUrl": "https://doi.org/10.1053/gast.2001.26279",
      "verified": true
    },
    {
      "title": "A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998",
      "journal": "Inflammatory Bowel Diseases",
      "year": 2000,
      "citationCount": 1134,
      "doi": "10.1097/00054725-200002000-00002",
      "sourceUrl": "https://doi.org/10.1097/00054725-200002000-00002",
      "verified": true
    },
    {
      "title": "Certolizumab Pegol for the Treatment of Crohn's Disease",
      "journal": "New England Journal of Medicine",
      "year": 2007,
      "citationCount": 1130,
      "doi": "10.1056/nejmoa067594",
      "sourceUrl": "https://doi.org/10.1056/nejmoa067594",
      "verified": true
    },
    {
      "title": "Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis",
      "journal": "New England Journal of Medicine",
      "year": 2019,
      "citationCount": 1124,
      "doi": "10.1056/nejmoa1900750",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1900750",
      "verified": true
    },
    {
      "title": "The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota",
      "journal": "Gastroenterology",
      "year": 2002,
      "citationCount": 1111,
      "doi": "10.1053/gast.2002.32362",
      "sourceUrl": "https://doi.org/10.1053/gast.2002.32362",
      "verified": true
    },
    {
      "title": "Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease",
      "journal": "New England Journal of Medicine",
      "year": 2012,
      "citationCount": 1108,
      "doi": "10.1056/nejmoa1203572",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1203572",
      "verified": true
    },
    {
      "title": "Maintenance Therapy with Certolizumab Pegol for Crohn's Disease",
      "journal": "New England Journal of Medicine",
      "year": 2007,
      "citationCount": 1042,
      "doi": "10.1056/nejmoa062897",
      "sourceUrl": "https://doi.org/10.1056/nejmoa062897",
      "verified": true
    },
    {
      "title": "Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial",
      "journal": "Gut",
      "year": 2007,
      "citationCount": 1025,
      "doi": "10.1136/gut.2006.106781",
      "sourceUrl": "https://doi.org/10.1136/gut.2006.106781",
      "verified": true
    },
    {
      "title": "The Natural History of Adult Crohn's Disease in Population-Based Cohorts",
      "journal": "The American Journal of Gastroenterology",
      "year": 2009,
      "citationCount": 1011,
      "doi": "10.1038/ajg.2009.579",
      "sourceUrl": "https://doi.org/10.1038/ajg.2009.579",
      "verified": true
    },
    {
      "title": "Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease",
      "journal": "Gastroenterology",
      "year": 2008,
      "citationCount": 1010,
      "doi": "10.1053/j.gastro.2008.01.012",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2008.01.012",
      "verified": true
    },
    {
      "title": "Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab",
      "journal": "Annals of Internal Medicine",
      "year": 2007,
      "citationCount": 954,
      "doi": "10.7326/0003-4819-146-12-200706190-00159",
      "sourceUrl": "https://doi.org/10.7326/0003-4819-146-12-200706190-00159",
      "verified": true
    },
    {
      "title": "Natalizumab Induction and Maintenance Therapy for Crohn's Disease",
      "journal": "New England Journal of Medicine",
      "year": 2005,
      "citationCount": 919,
      "doi": "10.1056/nejmoa043335",
      "sourceUrl": "https://doi.org/10.1056/nejmoa043335",
      "verified": true
    },
    {
      "title": "Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis",
      "journal": "Gastroenterology",
      "year": 2013,
      "citationCount": 910,
      "doi": "10.1053/j.gastro.2013.05.048",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2013.05.048",
      "verified": true
    },
    {
      "title": "Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis",
      "journal": "Gastroenterology",
      "year": 2011,
      "citationCount": 909,
      "doi": "10.1053/j.gastro.2011.06.054",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2011.06.054",
      "verified": true
    },
    {
      "title": "Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial",
      "journal": "Gastroenterology",
      "year": 2001,
      "citationCount": 905,
      "doi": "10.1053/gast.2001.28674",
      "sourceUrl": "https://doi.org/10.1053/gast.2001.28674",
      "verified": true
    },
    {
      "title": "The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients",
      "journal": "Gastroenterology",
      "year": 2003,
      "citationCount": 904,
      "doi": "10.1053/j.gastro.2003.10.047",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2003.10.047",
      "verified": true
    },
    {
      "title": "Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry",
      "journal": "Clinical Gastroenterology and Hepatology",
      "year": 2006,
      "citationCount": 904,
      "doi": "10.1016/j.cgh.2006.03.002",
      "sourceUrl": "https://doi.org/10.1016/j.cgh.2006.03.002",
      "verified": true
    },
    {
      "title": "Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial",
      "journal": "The Lancet",
      "year": 2017,
      "citationCount": 877,
      "doi": "10.1016/s0140-6736(17)32641-7",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(17)32641-7",
      "verified": true
    },
    {
      "title": "Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial",
      "journal": "Gut",
      "year": 2011,
      "citationCount": 872,
      "doi": "10.1136/gut.2010.221127",
      "sourceUrl": "https://doi.org/10.1136/gut.2010.221127",
      "verified": true
    },
    {
      "title": "Anti–Interleukin-12 Antibody for Active Crohn's Disease",
      "journal": "New England Journal of Medicine",
      "year": 2004,
      "citationCount": 850,
      "doi": "10.1056/nejmoa033402",
      "sourceUrl": "https://doi.org/10.1056/nejmoa033402",
      "verified": true
    },
    {
      "title": "The safety of vedolizumab for ulcerative colitis and Crohn's disease",
      "journal": "Gut",
      "year": 2016,
      "citationCount": 788,
      "doi": "10.1136/gutjnl-2015-311079",
      "sourceUrl": "https://doi.org/10.1136/gutjnl-2015-311079",
      "verified": true
    },
    {
      "title": "Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis",
      "journal": "New England Journal of Medicine",
      "year": 2012,
      "citationCount": 786,
      "doi": "10.1056/nejmoa1112168",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1112168",
      "verified": true
    },
    {
      "title": "Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry",
      "journal": "The American Journal of Gastroenterology",
      "year": 2012,
      "citationCount": 777,
      "doi": "10.1038/ajg.2012.218",
      "sourceUrl": "https://doi.org/10.1038/ajg.2012.218",
      "verified": true
    },
    {
      "title": "Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity Index",
      "journal": "Mayo Clinic Proceedings",
      "year": 1994,
      "citationCount": 774,
      "doi": "10.1016/s0025-6196(12)61634-6",
      "sourceUrl": "https://doi.org/10.1016/s0025-6196(12)61634-6",
      "verified": true
    },
    {
      "title": "Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort",
      "journal": "Gastroenterology",
      "year": 2010,
      "citationCount": 766,
      "doi": "10.1053/j.gastro.2010.06.070",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2010.06.070",
      "verified": true
    },
    {
      "title": "A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease",
      "journal": "Gastroenterology",
      "year": 2008,
      "citationCount": 738,
      "doi": "10.1053/j.gastro.2008.07.014",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2008.07.014",
      "verified": true
    },
    {
      "title": "Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis",
      "journal": "Gastroenterology",
      "year": 2013,
      "citationCount": 709,
      "doi": "10.1053/j.gastro.2013.06.010",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2013.06.010",
      "verified": true
    },
    {
      "title": "Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed",
      "journal": "Gastroenterology",
      "year": 2014,
      "citationCount": 686,
      "doi": "10.1053/j.gastro.2014.05.008",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2014.05.008",
      "verified": true
    },
    {
      "title": "AGA technical review on perianal Crohn’s disease",
      "journal": "Gastroenterology",
      "year": 2003,
      "citationCount": 682,
      "doi": "10.1016/j.gastro.2003.08.025",
      "sourceUrl": "https://doi.org/10.1016/j.gastro.2003.08.025",
      "verified": true
    },
    {
      "title": "A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease",
      "journal": "Gastroenterology",
      "year": 2002,
      "citationCount": 673,
      "doi": "10.1053/gast.2002.31072",
      "sourceUrl": "https://doi.org/10.1053/gast.2002.31072",
      "verified": true
    },
    {
      "title": "C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis",
      "journal": "The American Journal of Gastroenterology",
      "year": 2015,
      "citationCount": 651,
      "doi": "10.1038/ajg.2015.120",
      "sourceUrl": "https://doi.org/10.1038/ajg.2015.120",
      "verified": true
    },
    {
      "title": "Update on the incidence and prevalence of Crohnʼs disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000",
      "journal": "Inflammatory Bowel Diseases",
      "year": 2006,
      "citationCount": 642,
      "doi": "10.1002/ibd.20029",
      "sourceUrl": "https://doi.org/10.1002/ibd.20029",
      "verified": true
    },
    {
      "title": "Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival",
      "journal": "Gastroenterology",
      "year": 1998,
      "citationCount": 628,
      "doi": "10.1016/s0016-5085(98)70421-4",
      "sourceUrl": "https://doi.org/10.1016/s0016-5085(98)70421-4",
      "verified": true
    },
    {
      "title": "A gp130–Src–YAP module links inflammation to epithelial regeneration",
      "journal": "Nature",
      "year": 2015,
      "citationCount": 616,
      "doi": "10.1038/nature14228",
      "sourceUrl": "https://doi.org/10.1038/nature14228",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:15.000Z",
  "openalexId": "https://openalex.org/A5032150391"
}